Accelerated Pharma (Accelerated Pharma) Current Accrued Expense : $0.94 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Current Accrued Expense?

Accelerated Pharma's Current Accrued Expense for the quarter that ended in Mar. 2017 was $0.94 Mil.

Accelerated Pharma's quarterly Current Accrued Expense increased from Sep. 2016 ($0.37 Mil) to Dec. 2016 ($0.70 Mil) and increased from Dec. 2016 ($0.70 Mil) to Mar. 2017 ($0.94 Mil).

Accelerated Pharma's annual Current Accrued Expense increased from Dec. 2014 ($0.05 Mil) to Dec. 2015 ($1.37 Mil) but then declined from Dec. 2015 ($1.37 Mil) to Dec. 2016 ($0.70 Mil).

Accelerated Pharma Current Accrued Expense Historical Data

The historical data trend for Accelerated Pharma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Current Accrued Expense Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Current Accrued Expense

0.05

1.37

0.70

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Current Accrued Expense	Get a 7-Day Free Trial			-	0.29	0.37	0.70	0.94

Accelerated Pharma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Accelerated Pharma Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines